Published in J Immunol on May 17, 2010
Epigenetic modifications and human disease. Nat Biotechnol (2010) 7.29
The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-α. Nat Med (2012) 2.66
MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases. Transl Res (2011) 2.15
Inhibition of microRNA function by antimiR oligonucleotides. Silence (2012) 2.02
A ten-microRNA expression signature predicts survival in glioblastoma. PLoS One (2011) 1.87
Apoptosis and the target genes of microRNA-21. Chin J Cancer (2011) 1.74
Regulation of mammalian DNA methyltransferases: a route to new mechanisms. EMBO Rep (2011) 1.71
Epigenetic mechanisms and the development of asthma. J Allergy Clin Immunol (2012) 1.67
Functional characterization of the MECP2/IRAK1 lupus risk haplotype in human T cells and a human MECP2 transgenic mouse. J Autoimmun (2013) 1.65
A survey of small RNAs in human sperm. Hum Reprod (2011) 1.62
MSC Transplantation Improves Osteopenia via Epigenetic Regulation of Notch Signaling in Lupus. Cell Metab (2015) 1.49
A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1. J Mol Cell Biol (2012) 1.42
Wolbachia uses a host microRNA to regulate transcripts of a methyltransferase, contributing to dengue virus inhibition in Aedes aegypti. Proc Natl Acad Sci U S A (2013) 1.42
Silencing of microRNA-21 in vivo ameliorates autoimmune splenomegaly in lupus mice. EMBO Mol Med (2011) 1.38
Identification of a common lupus disease-associated microRNA expression pattern in three different murine models of lupus. PLoS One (2010) 1.30
HCV-induced miR-21 contributes to evasion of host immune system by targeting MyD88 and IRAK1. PLoS Pathog (2013) 1.29
The clinical significance of MiR-148a as a predictive biomarker in patients with advanced colorectal cancer. PLoS One (2012) 1.26
Epigenetic mechanisms in systemic lupus erythematosus and other autoimmune diseases. Trends Mol Med (2011) 1.25
MicroRNA-301a regulation of a T-helper 17 immune response controls autoimmune demyelination. Proc Natl Acad Sci U S A (2012) 1.24
Structural analysis of autoinhibition in the Ras-specific exchange factor RasGRP1. Elife (2013) 1.22
Regulation and Function of the RasGRP Family of Ras Activators in Blood Cells. Genes Cancer (2011) 1.19
The microRNA-148/152 family: multi-faceted players. Mol Cancer (2013) 1.14
Comprehensive analysis of miRNA expression in T-cell subsets of rheumatoid arthritis patients reveals defined signatures of naive and memory Tregs. Genes Immun (2014) 1.13
MicroRNAs and autoimmunity. Curr Opin Immunol (2012) 1.12
Diagnostic, functional, and therapeutic roles of microRNA in allergic diseases. J Allergy Clin Immunol (2013) 1.11
Overexpression of microRNA-21 is associated with elevated pro-inflammatory cytokines in dominant-negative TGF-β receptor type II mouse. J Autoimmun (2013) 1.08
Transcriptomic signatures in cartilage ageing. Arthritis Res Ther (2013) 1.07
MicroRNAs--novel regulators of systemic lupus erythematosus pathogenesis. Nat Rev Rheumatol (2012) 1.06
MicroRNA-mediated drug resistance in breast cancer. Clin Epigenetics (2011) 1.06
MicroRNAs in systemic rheumatic diseases. Arthritis Res Ther (2011) 1.05
The role of miR-148a in gastric cancer. J Cancer Res Clin Oncol (2014) 1.03
Decreased expression of microRNA-21 correlates with the imbalance of Th17 and Treg cells in patients with rheumatoid arthritis. J Cell Mol Med (2014) 1.03
Bromodomain coactivators in cancer, obesity, type 2 diabetes, and inflammation. Discov Med (2010) 1.03
Circulating immune cell and microRNA in patients with uveal melanoma developing metastatic disease. Mol Immunol (2013) 1.02
Promoter hypomethylation results in increased expression of protein phosphatase 2A in T cells from patients with systemic lupus erythematosus. J Immunol (2011) 1.02
MicroRNAs in rheumatoid arthritis. FEBS Lett (2011) 1.02
Genome-wide DNA methylation analysis identifies hypomethylated genes regulated by FOXP3 in human regulatory T cells. Blood (2013) 1.01
DNMT1 is regulated by ATP-citrate lyase and maintains methylation patterns during adipocyte differentiation. Mol Cell Biol (2013) 1.01
Advances in lupus genetics and epigenetics. Curr Opin Rheumatol (2014) 0.98
Microarray analysis of microRNA expression in peripheral blood mononuclear cells of critically ill patients with influenza A (H1N1). BMC Infect Dis (2013) 0.98
Epigenetics in systemic lupus erythematosus: leading the way for specific therapeutic agents. Int J Clin Rheumtol (2011) 0.98
MicroRNA analysis of microdissected normal squamous esophageal epithelium and tumor cells. Am J Cancer Res (2011) 0.97
Epigenetics and autoimmune diseases. Autoimmune Dis (2012) 0.97
The role of epigenetic variation in the pathogenesis of systemic lupus erythematosus. Arthritis Res Ther (2011) 0.97
MicroRNA function in NK-cell biology. Immunol Rev (2013) 0.96
microRNA expression in peripheral blood cells following acute ischemic stroke and their predicted gene targets. PLoS One (2014) 0.96
Interplay between DNA repair and inflammation, and the link to cancer. Crit Rev Biochem Mol Biol (2014) 0.96
Zinc-induced Dnmt1 expression involves antagonism between MTF-1 and nuclear receptor SHP. Nucleic Acids Res (2012) 0.94
T cells as a therapeutic target in SLE. Lupus (2015) 0.94
Milk: an exosomal microRNA transmitter promoting thymic regulatory T cell maturation preventing the development of atopy? J Transl Med (2014) 0.94
The microRNA miR-148a functions as a critical regulator of B cell tolerance and autoimmunity. Nat Immunol (2016) 0.93
Cardiovascular risk in systemic autoimmune diseases: epigenetic mechanisms of immune regulatory functions. Clin Dev Immunol (2011) 0.92
Targeting lymphocyte signaling pathways as a therapeutic approach to systemic lupus erythematosus. Curr Opin Rheumatol (2011) 0.92
MicroRNA-494 is a master epigenetic regulator of multiple invasion-suppressor microRNAs by targeting ten eleven translocation 1 in invasive human hepatocellular carcinoma tumors. Hepatology (2015) 0.92
MicroRNA regulation of lymphocyte tolerance and autoimmunity. J Clin Invest (2015) 0.92
An insight into the various regulatory mechanisms modulating human DNA methyltransferase 1 stability and function. Epigenetics (2012) 0.92
Effects of exercise on microRNA expression in young males peripheral blood mononuclear cells. Clin Transl Sci (2012) 0.92
Regulation of dendritic cell activation by microRNA let-7c and BLIMP1. J Clin Invest (2013) 0.92
MiR-320a is downregulated in patients with myasthenia gravis and modulates inflammatory cytokines production by targeting mitogen-activated protein kinase 1. J Clin Immunol (2012) 0.92
microRNA-mediated regulation of innate immune response in rheumatic diseases. Arthritis Res Ther (2013) 0.91
MicroRNA control in the development of systemic autoimmunity. Arthritis Res Ther (2013) 0.91
Cholinesterase-Targeting microRNAs Identified in silico Affect Specific Biological Processes. Front Mol Neurosci (2011) 0.90
Sex differences in the expression of lupus-associated miRNAs in splenocytes from lupus-prone NZB/WF1 mice. Biol Sex Differ (2013) 0.90
ACVR1, a therapeutic target of fibrodysplasia ossificans progressiva, is negatively regulated by miR-148a. Int J Mol Sci (2012) 0.90
Decreased microRNA(miR)-145 and increased miR-224 expression in T cells from patients with systemic lupus erythematosus involved in lupus immunopathogenesis. Clin Exp Immunol (2013) 0.90
Tumor suppressor miR-375 regulates MYC expression via repression of CIP2A coding sequence through multiple miRNA-mRNA interactions. Mol Biol Cell (2013) 0.90
Rasgrp1 mutation increases naive T-cell CD44 expression and drives mTOR-dependent accumulation of Helios⁺ T cells and autoantibodies. Elife (2013) 0.90
The Cancer Genome Atlas Analysis Predicts MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma. Mol Ther (2015) 0.89
Biomarkers in systemic lupus erythematosus: challenges and prospects for the future. Ther Adv Musculoskelet Dis (2013) 0.88
MicroRNA Regulation in Systemic Lupus Erythematosus Pathogenesis. Immune Netw (2014) 0.88
Inhibition of DNA methyltransferase activity and expression by treatment with the pan-deacetylase inhibitor panobinostat in hepatocellular carcinoma cell lines. BMC Cancer (2012) 0.88
MicroRNAs in lupus. Autoimmunity (2014) 0.87
A diverse array of genetic factors contribute to the pathogenesis of systemic lupus erythematosus. Orphanet J Rare Dis (2013) 0.87
Epigenetic and molecular profiles of erythroid cells after hydroxyurea treatment in sickle cell anemia. Blood (2011) 0.86
The 3D tissue microenvironment modulates DNA methylation and E-cadherin expression in squamous cell carcinoma. Epigenetics (2012) 0.86
Milk: an epigenetic amplifier of FTO-mediated transcription? Implications for Western diseases. J Transl Med (2015) 0.85
MicroRNA-148a can regulate runt-related transcription factor 3 gene expression via modulation of DNA methyltransferase 1 in gastric cancer. Mol Cells (2013) 0.84
Autoimmune disease in the epigenetic era: how has epigenetics changed our understanding of disease and how can we expect the field to evolve? Expert Rev Clin Immunol (2015) 0.84
DNA methylation modulates HRES1/p28 expression in B cells from patients with Lupus. Autoimmunity (2013) 0.84
Epigenetic alterations and microRNA misexpression in cancer and autoimmune diseases: a critical review. Clin Rev Allergy Immunol (2014) 0.84
Hepatitis C virus core protein down-regulates p21(Waf1/Cip1) and inhibits curcumin-induced apoptosis through microRNA-345 targeting in human hepatoma cells. PLoS One (2013) 0.84
Perspectives on epigenetic-based immune intervention for rheumatic diseases. Arthritis Res Ther (2013) 0.83
MicroRNAs implicated in the immunopathogenesis of lupus nephritis. Clin Dev Immunol (2013) 0.83
Tumor-suppressive miR148a is silenced by CpG island hypermethylation in IDH1-mutant gliomas. Clin Cancer Res (2014) 0.83
Reduced susceptibility of DNA methyltransferase 1 hypomorphic (Dnmt1N/+) mice to hepatic steatosis upon feeding liquid alcohol diet. PLoS One (2012) 0.83
MicroRNAs, Major Players in B Cells Homeostasis and Function. Front Immunol (2014) 0.83
Transcriptional regulation of the protocadherin β cluster during Her-2 protein-induced mammary tumorigenesis results from altered N-glycan branching. J Biol Chem (2012) 0.83
Dissecting complex epigenetic alterations in human lupus. Arthritis Res Ther (2013) 0.82
Regulation of RasGRP1 function in T cell development and activation by its unique tail domain. PLoS One (2012) 0.82
Function and mechanism of tumor suppressor gene LRRC4/NGL-2. Mol Cancer (2014) 0.82
Role of miRNAs in CD4 T cell plasticity during inflammation and tolerance. Front Genet (2013) 0.82
Novel insights into miRNA in lung and heart inflammatory diseases. Mediators Inflamm (2014) 0.81
miRNA signature of mouse helper T cell hyper-proliferation. PLoS One (2013) 0.81
New insights into the immunopathogenesis of systemic lupus erythematosus. Nat Rev Rheumatol (2016) 0.81
The Role of Mir-148a in Cancer. J Cancer (2016) 0.80
The real culprit in systemic lupus erythematosus: abnormal epigenetic regulation. Int J Mol Sci (2015) 0.80
MicroRNAs Regulating Signaling Pathways: Potential Biomarkers in Systemic Sclerosis. Genomics Proteomics Bioinformatics (2015) 0.80
miRNAs in the Pathogenesis of Systemic Lupus Erythematosus. Int J Mol Sci (2015) 0.80
Cytokines and MicroRNAs as Candidate Biomarkers for Systemic Lupus Erythematosus. Int J Mol Sci (2015) 0.79
Initial sequencing and comparative analysis of the mouse genome. Nature (2002) 96.15
Variable selection for multivariate failure time data. Biometrika (2005) 22.95
Covariation in frequencies of substitution, deletion, transposition, and recombination during eutherian evolution. Genome Res (2003) 11.12
The receptor-like kinase SERK3/BAK1 is a central regulator of innate immunity in plants. Proc Natl Acad Sci U S A (2007) 5.76
Distinguishing regulatory DNA from neutral sites. Genome Res (2003) 5.63
Effect of iodine intake on thyroid diseases in China. N Engl J Med (2006) 5.46
Sequential transphosphorylation of the BRI1/BAK1 receptor kinase complex impacts early events in brassinosteroid signaling. Dev Cell (2008) 3.58
Regulatory potential scores from genome-wide three-way alignments of human, mouse, and rat. Genome Res (2004) 3.53
Identification and functional analysis of in vivo phosphorylation sites of the Arabidopsis BRASSINOSTEROID-INSENSITIVE1 receptor kinase. Plant Cell (2005) 3.48
MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum (2009) 3.44
VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging α4β1-positive osteoclast progenitors. Cancer Cell (2011) 3.23
BAK1 and BKK1 regulate brassinosteroid-dependent growth and brassinosteroid-independent cell-death pathways. Curr Biol (2007) 2.97
Genome-wide association study in Asian populations identifies variants in ETS1 and WDFY4 associated with systemic lupus erythematosus. PLoS Genet (2010) 2.74
OrthoDB: a hierarchical catalog of animal, fungal and bacterial orthologs. Nucleic Acids Res (2012) 2.68
The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-α. Nat Med (2012) 2.66
Large-scale analysis of association between GDF5 and FRZB variants and osteoarthritis of the hip, knee, and hand. Arthritis Rheum (2009) 2.47
Randomized controlled trial of the effects of remote ischemic preconditioning on children undergoing cardiac surgery: first clinical application in humans. J Am Coll Cardiol (2006) 2.30
PP2A activates brassinosteroid-responsive gene expression and plant growth by dephosphorylating BZR1. Nat Cell Biol (2011) 2.28
A semiparametric empirical likelihood method for biased sampling schemes with auxiliary covariates. Biometrics (2006) 2.07
OrthoDB: the hierarchical catalog of eukaryotic orthologs in 2011. Nucleic Acids Res (2010) 2.02
Dependence of effective molarity on linker length for an intramolecular protein-ligand system. J Am Chem Soc (2007) 1.98
Update on hybrid conjugate-view SPECT tumor dosimetry and response in 131I-tositumomab therapy of previously untreated lymphoma patients. J Nucl Med (2003) 1.95
IL-17RE is the functional receptor for IL-17C and mediates mucosal immunity to infection with intestinal pathogens. Nat Immunol (2011) 1.94
Impact of FDA drug risk communications on health care utilization and health behaviors: a systematic review. Med Care (2012) 1.91
Association of a functional IRF7 variant with systemic lupus erythematosus. Arthritis Rheum (2011) 1.78
In utero exposure to background levels of polychlorinated biphenyls and cognitive functioning among school-age children. Am J Epidemiol (2005) 1.75
In vitro sensitivity of Plasmodium falciparum from China-Myanmar border area to major ACT drugs and polymorphisms in potential target genes. PLoS One (2012) 1.74
Sin1 phosphorylation impairs mTORC2 complex integrity and inhibits downstream Akt signalling to suppress tumorigenesis. Nat Cell Biol (2013) 1.73
A quaternary SNARE-synaptotagmin-Ca2+-phospholipid complex in neurotransmitter release. J Mol Biol (2007) 1.73
miR-155 and its star-form partner miR-155* cooperatively regulate type I interferon production by human plasmacytoid dendritic cells. Blood (2010) 1.71
Health-related hot topic detection in online communities using text clustering. PLoS One (2013) 1.69
Assessment of genotype imputation methods. BMC Proc (2009) 1.68
A functional variant in microRNA-146a promoter modulates its expression and confers disease risk for systemic lupus erythematosus. PLoS Genet (2011) 1.68
A minimal domain responsible for Munc13 activity. Nat Struct Mol Biol (2005) 1.68
Interferon-α priming promotes lipid uptake and macrophage-derived foam cell formation: a novel link between interferon-α and atherosclerosis in lupus. Arthritis Rheum (2011) 1.68
Mutant epidermal growth factor receptor displays increased signaling through the phosphatidylinositol-3 kinase/AKT pathway and promotes radioresistance in cells of astrocytic origin. Oncogene (2004) 1.66
BRL1, a leucine-rich repeat receptor-like protein kinase, is functionally redundant with BRI1 in regulating Arabidopsis brassinosteroid signaling. Plant J (2004) 1.64
The remote ischemic preconditioning stimulus modifies inflammatory gene expression in humans. Physiol Genomics (2004) 1.63
Abnormalities of maternal thyroid function during pregnancy affect neuropsychological development of their children at 25-30 months. Clin Endocrinol (Oxf) (2010) 1.63
Separation and identification of major plant sphingolipid classes from leaves. J Biol Chem (2006) 1.63
Sex-specific association of X-linked Toll-like receptor 7 (TLR7) with male systemic lupus erythematosus. Proc Natl Acad Sci U S A (2010) 1.63
Vasculoprotective effect of insulin in the ischemic/reperfused canine heart: role of Akt-stimulated NO production. Cardiovasc Res (2005) 1.62
Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells. Arthritis Rheum (2008) 1.58
The glutathione-S-transferase Mu 1 null genotype modulates ozone-induced airway inflammation in human subjects. J Allergy Clin Immunol (2009) 1.57
Polymorphisms of the renin-angiotensin system genes predict progression of subclinical coronary atherosclerosis. Diabetes (2007) 1.56
Leucine deprivation increases hepatic insulin sensitivity via GCN2/mTOR/S6K1 and AMPK pathways. Diabetes (2011) 1.55
Identification of microRNA-31 as a novel regulator contributing to impaired interleukin-2 production in T cells from patients with systemic lupus erythematosus. Arthritis Rheum (2012) 1.54
An R package suite for microarray meta-analysis in quality control, differentially expressed gene analysis and pathway enrichment detection. Bioinformatics (2012) 1.54
Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK. Biochim Biophys Acta (2006) 1.54
Conserved alpha-helix acts as autoinhibitory sequence in AMP-activated protein kinase alpha subunits. J Biol Chem (2006) 1.54
Cancer and non-cancer mortality among Inhabitants in the high background radiation area of Yangjiang, China (1979-1998). Health Phys (2012) 1.50
Intravenous sildenafil is a potent pulmonary vasodilator in children with congenital heart disease. Circulation (2003) 1.50
Design, synthesis, and biological evaluation of isoquinoline-1,3,4-trione derivatives as potent caspase-3 inhibitors. J Med Chem (2006) 1.50
Association of genetic variants in complement factor H and factor H-related genes with systemic lupus erythematosus susceptibility. PLoS Genet (2011) 1.49
Meta-analysis followed by replication identifies loci in or near CDKN1B, TET3, CD80, DRAM1, and ARID5B as associated with systemic lupus erythematosus in Asians. Am J Hum Genet (2012) 1.49
The endoplasmic reticulum stress response is involved in apoptosis induced by aloe-emodin in HK-2 cells. Food Chem Toxicol (2011) 1.49
An unexpected distribution of sodium concentration in serum specimens stored for more than 30 years. Ann Epidemiol (2003) 1.48
MicroRNA-125a contributes to elevated inflammatory chemokine RANTES levels via targeting KLF13 in systemic lupus erythematosus. Arthritis Rheum (2010) 1.45
Polo-like kinase 1 and Chk2 interact and co-localize to centrosomes and the midbody. J Biol Chem (2002) 1.44
Saxagliptin added to a thiazolidinedione improves glycemic control in patients with type 2 diabetes and inadequate control on thiazolidinedione alone. J Clin Endocrinol Metab (2009) 1.44
Development of thyroid dysfunction and autoantibodies in Graves' multiplex families: an eight-year follow-up study in Chinese Han pedigrees. Thyroid (2011) 1.42
Insulin alleviates posttrauma cardiac dysfunction by inhibiting tumor necrosis factor-α-mediated reactive oxygen species production. Crit Care Med (2013) 1.42
Small molecule antagonizes autoinhibition and activates AMP-activated protein kinase in cells. J Biol Chem (2008) 1.41
Isoquinoline-1,3,4-trione derivatives inactivate caspase-3 by generation of reactive oxygen species. J Biol Chem (2008) 1.41
EGCG stimulates autophagy and reduces cytoplasmic HMGB1 levels in endotoxin-stimulated macrophages. Biochem Pharmacol (2011) 1.41
Maternal serum level of 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene and risk of cryptorchidism, hypospadias, and polythelia among male offspring. Am J Epidemiol (2002) 1.40
A novel unsupervised method to identify genes important in the anti-viral response: application to interferon/ribavirin in hepatitis C patients. PLoS One (2007) 1.39
TCP1 modulates brassinosteroid biosynthesis by regulating the expression of the key biosynthetic gene DWARF4 in Arabidopsis thaliana. Plant Cell (2010) 1.38
Pretreatment sequence diversity differences in the full-length hepatitis C virus open reading frame correlate with early response to therapy. J Virol (2007) 1.38
Genetic evidence for an indispensable role of somatic embryogenesis receptor kinases in brassinosteroid signaling. PLoS Genet (2012) 1.37
National trends in ambulatory asthma treatment, 1997-2009. J Gen Intern Med (2011) 1.37
Recent advances in understanding the biochemical and molecular mechanism of diabetic nephropathy. Biochem Biophys Res Commun (2013) 1.36
Design and inference for cancer biomarker study with an outcome and auxiliary-dependent subsampling. Biometrics (2009) 1.34
Electrical impedance myography for monitoring motor neuron loss in the SOD1 G93A amyotrophic lateral sclerosis rat. Clin Neurophysiol (2011) 1.32
Actinomycetes for marine drug discovery isolated from mangrove soils and plants in China. Mar Drugs (2009) 1.31
MMP13 is a critical target gene during the progression of osteoarthritis. Arthritis Res Ther (2013) 1.31
Selective IgA deficiency in autoimmune diseases. Mol Med (2011) 1.31
In vivo dynamics and distinct functions of hypoxia in primary tumor growth and organotropic metastasis of breast cancer. Cancer Res (2010) 1.31
Genomic insights into salt adaptation in a desert poplar. Nat Commun (2013) 1.30